FDA Inspection
Biocon Pharma LimitedBiocon Pharma Limited – FDA Inspection, Jun 2, 2023
Record Details
This FDA Inspection record concerns Biocon Pharma Limited, with an inspection on June 2, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 3bf28887-93d0-41f7-8975-1d4f7c569ae1
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1209086
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Biocon Pharma Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 15, 2019 | Not classified | Office of Inspections and Investigations | |
| November 9, 2018 | Not classified | Office of Inspections and Investigations | |
| May 2, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Biocon Pharma Limited
- FDA Inspection 1083851 - 2019-02-15
- FDA Inspection 1075123 - 2018-11-09
- FDA Inspection 1056467 - 2018-05-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.